TAOX
TAO Synergies Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.89
−4.07%Margins
Gross margin
99.9%
EBITDA margin
-1084.8%
EBIT margin
-1085.2%
Net margin
-2155.5%
FCF margin
-803.0%
-96.3%
Return on equity
-78.9%
Return on assets
-48.5%
Return on invested capital
0.03x
Asset turnover
-$6.2M
Cash from operations
$2.56
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026